Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results.
Thatcher
N
N
Christie Hospital, Manchester, U.K.
Taylor
P
P
Carroll
K B
KB
Loriaux
E M
EM
Palmer
P
P
Franks
C R
CR
D000230:Adenocarcinoma / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D007262:Infusions, Intravenous; D007263:Infusions, Parenteral; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000009:adverse effects; D008175:Lung Neoplasms / Q000188:drug therapy*; D008654:Mesothelioma / Q000188:drug therapy*; D010994:Pleura; D010997:Pleural Neoplasms / Q000188:drug therapy*
D007376:Interleukin-2